CoChat

Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity

Andrejevic, Sladjana, Jeremic, Ivica, Sefik-Bukilica, Mirjana, Nikolic, Milos, Stojimirovic, Biljana, Bonaci-Nikolic, Branka · 2013 · Clinical Rheumatology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

We assessed the relationship between the serum levels of antibodies against double-stranded DNA (dsDNA), C1q, nucleosomes, histones, C3 and C4 complement components with one another, with organ involvement and overall disease activity in patients with systemic lupus erythematosus (SLE). One hundred seventy-five sera from 99 patients with SLE, 31 sera of patients with other connective tissue diseases, and 20 sera from healthy blood donors were tested. SLE disease activity was assessed by modified SLEDAI-2K (M-SLEDAI-2K), not including complement and anti-dsDNA descriptors. Anti-dsDNA antibodies were measured by indirect immunofluorescence on Crithidia luciliae (CLIFT), standard enzyme-linked immunosorbent assay (ELISA) and ELISA for high-avidity antibodies. The most significant risk factor for renal involvement were anti-C1q antibodies (OR = 3.88, p 5) (OR = 5.5, p < 0.01). The presence of high-avidity anti-dsDNA antibodies represented a risk for renal, joint, and most importantly for serosal involvement. Our results suggest that simple and reliable ELISA for high-avidity anti-dsDNA antibodies is the test of good clinical utility for the assessment of global SLE activity.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10067-013-2330-3

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

The citation lists are queued

They are fetched later and appear here then.

References 41 · Cited by 56

Metadata

Authors
Andrejevic, S., Jeremic, I., Sefik-Bukilica, M., Nikolic, M., Stojimirovic, B., & Bonaci-Nikolic, B.
Affiliations
University of Belgrade (RS)
Venue
Clinical Rheumatology
Published
2013-07-16
Volume
32
Issue
11
Pages
1619-1626
ISSN
  • 0770-3198 (ISSN-L)
  • 1434-9949
OpenAlex
W2006161397
Cited by
56
References
41
Citations by year
2026: 5 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 11 · 2020: 1 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 1 · 2013: 1
FWCI
2.46
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Clinical Rheumatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
systemic lupus erythematosus, disease activity, SLEDAI-2K, complement C3, anti-C1q antibodies, anti-histone antibodies, anti-nucleosome antibodies, renal involvement, polyserositis, connective tissue diseases, autoantibodies, risk factors
MeSH terms
Adolescent, Adult, Aged, Autoantibodies, Complement System Proteins, DNA, Enzyme-Linked Immunosorbent Assay, Female, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Severity of Illness Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity. https://app.cochat.ai/papers/10.1007/s10067-013-2330-3
The paper
Andrejevic, S., Jeremic, I., Sefik-Bukilica, M., Nikolic, M., Stojimirovic, B., & Bonaci-Nikolic, B. (2013). Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity. Clinical Rheumatology. https://doi.org/10.1007/s10067-013-2330-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.